课题基金 / 基金详情

RUI: Charge Modified Antibody for Robust and Directional Adsorption onto Gold Nanoparticles

RUI: Charge Modified Antibody for Robust and Directional Adsorption onto Gold Nanoparticles
RUI:电荷修饰抗体,可牢固、定向吸附到金纳米颗粒上
批准号:
1807126
负责人:
Jeremy Driskell
金额:
$34.49万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2022-08-31

项目摘要

项目成果

Jeremy Driskell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The need to protect against biological threats and to develop effective drug therapies requires the development of novel detection strategies. The unique properties of gold nanoparticles (AuNPs) make them candidates for materials used in detection technologies. Critical for the success of emerging detection technologies is the attachment of proteins, i.e., antibodies, onto the surface of the AuNPs. Despite extensive efforts in the area of antibody-AuNP conjugation chemistry, current attachment chemistries are not universally applicable to all antibodies, often diminish the function of the antibody, and result in compounds with limited stability. In an effort to address these challenges and to realize the full potential of AuNP-enabled assays, Dr. Jeremy Driskell and his research group at Illinois State University are investigating the underlying principles of the antibody-AuNP interaction. This research is conducted with the support of the Macromolecular, Supramolecular and Nanochemistry Program. These studies will promote the rational design of highly active and stable antibody-AuNP conjugates. The project provides an intense research experience to undergraduate students who learn advanced analytical techniques and gain an appreciation for a multidisciplinary approach to problem solving. Additionally, Dr. Driskell and his undergraduate students participate in the Illinois Summer Research Academy, an educational outreach program that provides high school students from across the nation with an opportunity to work in a research laboratory. Despite many successful examples of antibody-AuNP conjugates, immobilization chemistry still presents a challenge. Direct adsorption of the antibody onto AuNPs is often effective; however, adsorption conditions vary among proteins in an unpredictable manner and the activity of the conjugate is variable. Dr. Driskell's research seeks to identify the underlying principles that cause some antibodies to adsorb onto AuNPs to form stable, highly active conjugates, while other antibodies adsorb weakly and/or exhibit poor binding activity. Dr. Driskell's lab investigates the adsorption dynamics of antibodies onto AuNPs by measuring the adsorption affinity, orientation, reversibility, and displacement by other proteins. Antibodies are chemically modified to precisely alter the protein charge. A systematic investigation into adsorption elucidates the foundational principles needed to build a predictive model for effective surface modification. These efforts support Dr. Driskell's long-term goal of developing a strategy to immobilize antibodies onto AuNPs to form highly active, oriented, and stable conjugates for use in AuNP-enabled immunoassays.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acs.langmuir.9b01900
发表时间: 2019-08-13
期刊: LANGMUIR
影响因子: 3.9
作者: [Ruiz, Guadalupe, Ryan, Nicki, Driskell, Jeremy D.]
通讯作者: Driskell, Jeremy D.
DOI: 10.1021/acs.langmuir.1c00100
发表时间: 2021-02-23
期刊: LANGMUIR
影响因子: 3.9
作者: [Okyem, Samuel, Awotunde, Olatunde, Driskell, Jeremy D.]
通讯作者: Driskell, Jeremy D.
DOI: 10.1016/j.talanta.2020.121739
发表时间: 2021-02-01
期刊: TALANTA
影响因子: 6.1
作者: [Frimpong, Richard, Jang, Wongi, Driskell, Jeremy D.]
通讯作者: Driskell, Jeremy D.
DOI: 10.1021/acs.bioconjchem.9b00123
发表时间: 2019-04-01
期刊: BIOCONJUGATE CHEMISTRY
影响因子: 4.7
作者: [Ruiz, Guadalupe, Tripathi, Kiran, Driskell, Jeremy D.]
通讯作者: Driskell, Jeremy D.
RUI: Chemically Modified Enzymes to Control Adsorption on Gold Nanoparticles for Enhanced Structure/Function
国内基金
海外基金
CHARGE综合征致病基因CHD7介导的三维转录调控网络研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    51万元
  • 批准年份:
    2022
  • 负责人:
    朱艳芬
  • 依托单位:
Sema3E在CHARGE综合症中的作用及机制研究
  • 批准号:
    81160144
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    52.0万元
  • 批准年份:
    2011
  • 负责人:
    徐洪
  • 依托单位: